Clik here to view.
Hanmi Pharmaceutical : Once-Weekly Insulin Combination, ‘LAPSInsulin Combo’,...
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) made an oral presentation on the non-clinical results of once weekly insulin and GLP-1 combination drug ‘LAPSInsulin Combo’ at the 75th...
View ArticleClik here to view.
New Data Presented at ADA Demonstrate Early Effect of EndoBarrier Therapy on...
LEXINGTON, Mass. & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company, provides innovative treatments for type 2 diabetes and obesity, today announced new data showing the effect of...
View ArticleClik here to view.
CEL-SCI is Cleared to Start Patient Enrollment for Its Phase 3 Cancer...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that CEL-SCI is now cleared to start patient enrollment in Thailand in its ongoing Phase 3 trial with its...
View ArticleClik here to view.
Hanmi Pharmaceutical: Efpeglenatide (GLP-1 Analog), the Promising Potential...
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) announced that they presented 5 clinical and non-clinical studies with ‘efpeglenatide (LAPSCA-Exendin-4)’ at the 75th ADA Scientific...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals Closes Purchase of cGMP Facility for...
SAN DIEGO Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for pharmaceutical drug discovery and regenerative medicine, today announced...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals完成对cGMP设施的收购，用于生产面向细胞疗法应用的临床级细胞
圣迭戈 (美国商业资讯) — Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”)是开发面向药品发现和再生医学的专用细胞的领先者，该公司今天宣布已完成对一处新设施的收购，用于其按现行药品生产质量管理规范(cGMP)生产面向细胞疗法应用的临床级细胞。...
View ArticleClik here to view.
Elekta CE Marks Leksell Gamma Knife® Icon™, designed to treat a more...
STOCKHOLM, Sweden Regulatory News: Elekta has CE marked its Leksell Gamma Knife® Icon™ (http://www.careforthebrain.com/) precision radiosurgery system, making this latest generation Leksell Gamma...
View ArticleClik here to view.
Oral Presentation Evaluating Pooled Data on OTEZLA® (apremilast) for...
BOUDRY, Switzerland Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the findings from a long-term (104-week) post-hoc analysis of...
View ArticleClik here to view.
Annoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive...
BEIJING & SAN DIEGO Annoroad and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based...
View ArticleClik here to view.
Merck and Samsung Bioepis Announce Pivotal Phase 3 Studies for...
KENILWORTH, N.J. & SEOUL, South Korea Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of...
View ArticleClik here to view.
PeptiDream Announces Milestone in Macrocyclic Peptide Drug Discovery Alliance...
TOKYO PeptiDream Inc., a Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today the achievement of a milestone in one of the discovery programs in its alliance with...
View ArticleClik here to view.
Acelity Supports Education and Development of Early-Stage Surgeons
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, is hosting the Acelity Surgical Wound Forum (ASWF), which starts today in Prague, Czech Republic. ASWF is a three-day...
View ArticleClik here to view.
Carna Biosciences Announces Collaboration With Johnson & Johnson Innovation
SUNNYVALE, Calif. Carna Biosciences today announced a worldwide licensing agreement with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical companies of Johnson & Johnson, to...
View ArticleClik here to view.
Pharma Sales Forecast to Grow 5% Annually Through to 2020, Industry’s R&D...
LONDON & BOSTON & TOKYO Life science market intelligence firm, Evaluate Ltd, is launching their annual complimentary industry report, “EvaluatePharma World Preview 2015, Outlook to 2020,” at...
View ArticleClik here to view.
Waters Welcomes Chang Gung University as Taiwan’s First Centers of Innovation...
MILFORD, Mass. At a recent ceremony at Taipei’s Chang Gung University (CGU), Waters Corporation welcomed the University’s Healthy Aging Research Center as a Waters Centers of Innovation (COI)...
View ArticleClik here to view.
AmpliPhi Announces New Data Demonstrating Anti-Pseudomonal Bacteriophages...
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in the development of bacteriophage-based antibacterial therapies...
View ArticleClik here to view.
Clik here to view.
Bioventus为拓展国际业务提拔领导
北卡罗来纳州德罕 (美国商业资讯)–骨愈合解决方案领袖Bioventus®今日宣布了对其执行领导团队的升职任命，立即生效。Andrew Hosmer被提升为董事总经理，负责欧洲、中东和非洲的国际业务以及阿姆斯特丹国际总部的工作。同时提升Isabelle Levy-Unger为董事总经理，负责加拿大、拉丁美洲和亚太地区的国际业务。Andrew Hosmer和Isabelle...
View ArticleClik here to view.
Open Monoclonal Technology Announces OmniAb Alliance With Amgen
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Amgen Inc. with access to OMT’s proprietary OmniRat®, OmniMouse® and OmniFlic™ human antibody...
View ArticleClik here to view.
NTCELL® Clinical Study in Parkinson’s Meets Endpoints
SYDNEY & AUCKLAND, New Zealand Living Cell Technologies Limited (LCT) today announced results from a Phase I/IIa clinical study of NTCELL®, an experimental regenerative cell therapy being...
View Article